Celsee Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$99M
Celsee General Information
Description
Developer of an integrated comprehensive single-cell analysis product designed to identify, analyze and viably retrieve single cells directly from blood and tissue. The company's platform provide a practical approach to accurately analyze previously undetectable or rare cells to a scale of millions of single cells from an individual sample, enabling users to gently capture and isolate individual cells from heterogeneous blood and tissue suspensions.
Contact Information
Website
www.celsee.comCorporate Office
- 100 Phoenix Drive
- Suite 321
- Ann Arbor, MI 48108
- United States
Corporate Office
- 100 Phoenix Drive
- Suite 321
- Ann Arbor, MI 48108
- United States
Celsee Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Apr-2020 | $99M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 20-Dec-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 13-Nov-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 31-May-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 25-Apr-2017 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 30-Sep-2014 | Completed | Startup | |||
| 3. Grant | 21-Jun-2012 | Completed | Startup | |||
| 2. Grant | 01-Apr-2012 | $500K | Completed | Startup | ||
| 1. Grant | 08-Dec-2011 | $650K | Completed | Startup |
Celsee Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 24,290,576 | $0.001000 | 8% | $0.26 | $0.26 | 1x | $0.26 | 8.23% |
Celsee Comparisons
Industry
Financing
Details
Celsee Competitors (10)
One of Celsee’s 10 competitors is ViewRay, a Formerly VC-backed company based in Bedford, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ViewRay | Formerly VC-backed | Bedford, OH | ||||
| Advanced BioMatrix | Formerly VC-backed | Carlsbad, CA | ||||
| Nabsys | Formerly VC-backed | Providence, RI | ||||
| S2 Genomics | Formerly VC-backed | Livermore, CA | ||||
| CivaTech Oncology | Venture Capital-Backed | Durham, NC |
Celsee Patents
Celsee Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11504719-B2 | System and method for receiving and delivering a fluid for sample processing | Active | 12-Mar-2020 | ||
| US-12623225-B2 | System and method for receiving and delivering a fluid for sample processing | Active | 12-Mar-2020 | ||
| US-20210283613-A1 | System and method for receiving and delivering a fluid for sample processing | Active | 12-Mar-2020 | ||
| US-20230059461-A1 | System and method for receiving and delivering a fluid for sample processing | Active | 12-Mar-2020 | ||
| US-11724256-B2 | System and method for automated single cell processing and analyses | Active | 14-Jun-2019 | C12Q1/6813 |
Celsee Signals
Celsee Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Albany Capital (Australia) | Venture Capital | Minority | ||
| Ann Arbor SPARK | Accelerator/Incubator | Minority | ||
| First Step Fund | Not-For-Profit Venture Capital | Minority | ||
| Invest Detroit Ventures | Corporate Venture Capital | Minority |
Celsee FAQs
-
When was Celsee founded?
Celsee was founded in 2010.
-
Where is Celsee headquartered?
Celsee is headquartered in Ann Arbor, MI.
-
What is the size of Celsee?
Celsee has 40 total employees.
-
What industry is Celsee in?
Celsee’s primary industry is Other Devices and Supplies.
-
Is Celsee a private or public company?
Celsee is a Private company.
-
What is the current valuation of Celsee?
The current valuation of Celsee is .
-
What is Celsee’s current revenue?
The current revenue for Celsee is .
-
How much funding has Celsee raised over time?
Celsee has raised $36.2M.
-
Who are Celsee’s investors?
, Albany Capital (Australia), Ann Arbor SPARK, First Step Fund, and Invest Detroit Ventures are 5 of 7 investors who have invested in Celsee.
-
Who are Celsee’s competitors?
ViewRay, Advanced BioMatrix, Nabsys, S2 Genomics, and CivaTech Oncology are some of the 10 competitors of Celsee.
-
When was Celsee acquired?
Celsee was acquired on 01-Apr-2020.
-
Who acquired Celsee?
Celsee was acquired by Bio-Rad Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process